137 related articles for article (PubMed ID: 34328657)
21. The novel interplay between CD44 standard isoform and the caspase-1/IL1B pathway to induce hepatocellular carcinoma progression.
Li J; Zhang Y; Ruan R; He W; Qian Y
Cell Death Dis; 2020 Nov; 11(11):961. PubMed ID: 33168816
[TBL] [Abstract][Full Text] [Related]
22. Self-renewal and circulating capacities of metastatic hepatocarcinoma cells required for collaboration between TM4SF5 and CD44.
Lee D; Lee JW
BMB Rep; 2015 Mar; 48(3):127-8. PubMed ID: 25772760
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional Regulation of Siglec-15 by ETS-1 and ETS-2 in Hepatocellular Carcinoma Cells.
Sheng K; Wu Y; Lin H; Fang M; Xue C; Lin X; Lin X
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614238
[TBL] [Abstract][Full Text] [Related]
24. Osteopontin Regulates Hepatitis C Virus (HCV) Replication and Assembly by Interacting with HCV Proteins and Lipid Droplets and by Binding to Receptors αVβ3 and CD44.
Iqbal J; Sarkar-Dutta M; McRae S; Ramachandran A; Kumar B; Waris G
J Virol; 2018 Jul; 92(13):. PubMed ID: 29669827
[TBL] [Abstract][Full Text] [Related]
25. Siglec-15 recognition of sialoglycans on tumor cell lines can occur independently of sialyl Tn antigen expression.
Murugesan G; Correia VG; Palma AS; Chai W; Li C; Feizi T; Martin E; Laux B; Franz A; Fuchs K; Weigle B; Crocker PR
Glycobiology; 2021 Jan; 31(1):44-54. PubMed ID: 32501471
[TBL] [Abstract][Full Text] [Related]
26. Liver Cancer Initiation Requires p53 Inhibition by CD44-Enhanced Growth Factor Signaling.
Dhar D; Antonucci L; Nakagawa H; Kim JY; Glitzner E; Caruso S; Shalapour S; Yang L; Valasek MA; Lee S; Minnich K; Seki E; Tuckermann J; Sibilia M; Zucman-Rossi J; Karin M
Cancer Cell; 2018 Jun; 33(6):1061-1077.e6. PubMed ID: 29894692
[TBL] [Abstract][Full Text] [Related]
27. CD44 3'-Untranslated Region Functions as a Competing Endogenous RNA to Enhance NK Sensitivity of Liver Cancer Stem Cell by Regulating ULBP2 Expression.
Weng J; Han X; Liu K; Yang J; Wei S; Zhang Y; Zeng F; Li Y; Shen L; Gao Y
Int J Biol Sci; 2019; 15(8):1664-1675. PubMed ID: 31360109
[TBL] [Abstract][Full Text] [Related]
28. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
Toh TB; Lim JJ; Hooi L; Rashid MBMA; Chow EK
J Hepatol; 2020 Jan; 72(1):104-118. PubMed ID: 31541681
[TBL] [Abstract][Full Text] [Related]
29. Chitosan promotes cancer progression and stem cell properties in association with Wnt signaling in colon and hepatocellular carcinoma cells.
Chang PH; Sekine K; Chao HM; Hsu SH; Chern E
Sci Rep; 2017 Apr; 8():45751. PubMed ID: 28367998
[TBL] [Abstract][Full Text] [Related]
30. Transforming growth factor-β-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma.
Malfettone A; Soukupova J; Bertran E; Crosas-Molist E; Lastra R; Fernando J; Koudelkova P; Rani B; Fabra Á; Serrano T; Ramos E; Mikulits W; Giannelli G; Fabregat I
Cancer Lett; 2017 Apr; 392():39-50. PubMed ID: 28161507
[TBL] [Abstract][Full Text] [Related]
31. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein.
Chen S; Wang L; Yao B; Liu Q; Guo C
Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165
[TBL] [Abstract][Full Text] [Related]
32. Sialic acid-binding immunoglobulin-like lectin-15 expression on peritumoral macrophages is a favorable prognostic factor for primary central nervous system lymphoma patients.
Fudaba H; Momii Y; Hirakawa T; Onishi K; Asou D; Matsushita W; Kawasaki Y; Sugita K; Fujiki M
Sci Rep; 2021 Jan; 11(1):1206. PubMed ID: 33441719
[TBL] [Abstract][Full Text] [Related]
33. Lysosomal degradation of CD44 mediates ceramide nanoliposome-induced anoikis and diminished extravasation in metastatic carcinoma cells.
Haakenson JK; Khokhlatchev AV; Choi YJ; Linton SS; Zhang P; Zaki PM; Fu C; Cooper TK; Manni A; Zhu J; Fox TE; Dong C; Kester M
J Biol Chem; 2015 Mar; 290(13):8632-43. PubMed ID: 25681441
[TBL] [Abstract][Full Text] [Related]
34. Hyaluronan-CD44 interaction with neural Wiskott-Aldrich syndrome protein (N-WASP) promotes actin polymerization and ErbB2 activation leading to beta-catenin nuclear translocation, transcriptional up-regulation, and cell migration in ovarian tumor cells.
Bourguignon LY; Peyrollier K; Gilad E; Brightman A
J Biol Chem; 2007 Jan; 282(2):1265-80. PubMed ID: 17092940
[TBL] [Abstract][Full Text] [Related]
35. ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells.
Yuan S; Lei S; Wu S
Oncol Rep; 2013 Oct; 30(4):1715-22. PubMed ID: 23912592
[TBL] [Abstract][Full Text] [Related]
36. [Long non-coding RNA HULC affects downstream-related targets to regulate migration and invasion of hepatoma cells].
Zhou C; Wu H; Liu Y; Yin C; Yang B
Zhonghua Gan Zang Bing Za Zhi; 2018 Jul; 26(7):513-518. PubMed ID: 30317774
[No Abstract] [Full Text] [Related]
37. Immunopositivity for Siglec-15 in gastric cancer and its association with clinical and pathological parameters.
Quirino MWL; Pereira MC; Deodato de Souza MF; Pitta IDR; Da Silva Filho AF; Albuquerque MSS; Albuquerque APB; Martins MR; Pitta MGDR; Rêgo MJBM
Eur J Histochem; 2021 Mar; 65(1):. PubMed ID: 33666065
[TBL] [Abstract][Full Text] [Related]
38. The interaction between Siglec-15 and tumor-associated sialyl-Tn antigen enhances TGF-β secretion from monocytes/macrophages through the DAP12-Syk pathway.
Takamiya R; Ohtsubo K; Takamatsu S; Taniguchi N; Angata T
Glycobiology; 2013 Feb; 23(2):178-87. PubMed ID: 23035012
[TBL] [Abstract][Full Text] [Related]
39. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
[TBL] [Abstract][Full Text] [Related]
40. Musashi2 contributes to the maintenance of CD44v6+ liver cancer stem cells via notch1 signaling pathway.
Wang X; Wang R; Bai S; Xiong S; Li Y; Liu M; Zhao Z; Wang Y; Zhao Y; Chen W; Billiar TR; Cheng B
J Exp Clin Cancer Res; 2019 Dec; 38(1):505. PubMed ID: 31888685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
